Publication | Closed Access

Programmed death-1 (PD-1)/PD-1 ligand pathway–mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders

Autoimmune DisordersAutoimmune DiseaseImmunodeficienciesImmune RegulationImmunologyPathologyVirologyAntiviral ResponseAutoimmunityImmune SystemT Cell ImmunityImmune ResponsesImmunologic DiseaseImmunotherapyMedicineViral Immunity